M. Piccart

1.6k citations
23 papers · 1.1k indexed · 1 hit paper · h-index 9

M. Piccart

23 papers receiving 1.1k citations

Hit Papers

Randomized Intergroup Trial of Cisplatin-Paclitaxel Versu...20002026200820172000200400600

Peers

M. Piccart
Comparison fields: 5 of 68
  • Reproductive Medicine 677
  • Oncology 471
  • Surgery 416
  • Obstetrics and Gynecology 274
  • Molecular Biology 181
Replace C. Mangioni with:
C. Mangioni Italy
Scott Z. Fields United States
Marie‐Claude Renaud Canada
S Y Liao United States
Lisa Barroilhet United States
A.G.J. van der Zee Netherlands
Susan Schumer United States
Simona Scalone Italy
Ewan Brown United Kingdom
Eiichiro Tominaga Japan
M. Piccart relative to C. Mangioni Italy C. Mangioni's profile →
Citations per field
00.5×1.5×
C. Mangioni · 1×
Citations per year

Countries citing papers authored by M. Piccart

Since Specialization
Citations

This map shows the geographic impact of M. Piccart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Piccart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Piccart more than expected).

Fields of papers citing papers by M. Piccart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Piccart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Piccart. The network helps show where M. Piccart may publish in the future.

Co-authorship network of co-authors of M. Piccart

This figure shows the co-authorship network connecting the top 25 collaborators of M. Piccart. A scholar is included among the top collaborators of M. Piccart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Piccart. M. Piccart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 47
2 1
3 1
4 1
5 11
6
Better characterization of estrogen receptor (ER) positive luminal subtypes using genomic grade
7
7 1
8 7
9 17
10
Oxaliplatin (OXA) in patients (pts) with advanced ovarian cancer (AOC) after failure of topotecan (TOPO) based chemotherapy
1
11
Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Resultsbreakdown →
746
12 3
13 55
14 2
15 9
16 98
17 4
18 19
19
A prospective study of the correlation between Ca 125 serum levels and surgically verified tumor burden in ovarian cancer (OV-CA) patients (PTS)
3
20 86

About M. Piccart

M. Piccart is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Reproductive Medicine (677 citations), Obstetrics and Gynecology (274 citations) and Oncology (471 citations). M. Piccart has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Jean Klášterský, Hjalmar Lagast, F. Meunier, Franco M. Muggia, Yves Van Laethem, Danièle Weerts, John F. Sandbach, Nicoletta Colombo, Gary M. Clark and Daniel D. Von Hoff. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026